The aim of our study was to evaluate the significance of the Immuno-Reactive Trypsine (IRT) as a marker for exocrine pancreatic insufficiency, assessed on fecal elastase, in pancreatic sufficient and insufficient cystic fibrosis (CF) children. Patients and Methods: From August 2006 to January 2008, fifty-six children followed-up in CF Centre, Department of Pediatrics, Angers (France), were studied. From their fecal elastase concentration they were divided into 2 groups: pancreatic sufficient or insufficient (>200 mg/g of stool or ×100 mg/g of stool). For every patient, IRT concentration was assessed on a dried blood sample. Results: The fifty pancreatic sufficient patients all had IRT concentrations upper than 9.5 ng/mL, whatever their age. Thirty-four of the 41 pancreatic insufficient patients had IRT concentrations lower than 9.5 ng/mL whatever their age, and 33 of the 35 pancreatic insufficient patients over than 4 years-old had IRT concentrations lower than 9.5 ng/mL. IRT concentration lower than 9.5 ng/mL measured in a more than 4 years-old CF child permit to affirm that he has pancreatic insufficiency, with sensibility of 94%, specificity of 100%, positive predictive value of 100% and negative predictive value of 83%. Conclusion: From the age of 4 in cystic fibrosis children, IRT concentration is correlated with extern pancreatic status. This could be used as a marker for exocrine pancreatic insufficiency when difficulties to obtain stools in consultation.
The influence of genetic and epigenetic factors on functional status of pancreas in patients with cystic fibrosis and on course of the disease in general has been analysed. 96 cases of CF were verified at Lviv regional CF centre and 89 CF patients were under observation in terms from 2 month to 12 years. Among them 13 (13.4%) died − 9 (69.2%) girls and 4 (30.8%) boys. The studied group of patients was divided on the genotype differences and disease manifestation severity and the obtained results of glucose-toleration test, sonographical investigation data and faecal elastase-1 level were compared. It was determined that CFTR genotype influences on exocrine pancreatic insufficiency manifestation."Major" CFTR mutation associates with severe exocrine pancreatic insufficiency phenotype. "Minor" changes of alleles dominate on "severe" and could result sufficient exocrine function of pancreas. Both negative (for the F508del mutation) and positive (for the 3849+10kbC → T, R334W, 3272−11A>G mutations) correlations between genotype and the degree of exocrine pancreatic insufficiency have been revealed. CF patient genotype and the degree of exocrine pancreatic insufficiency don't seem to determine his endocrine status and dynamics of progression of fibrotic and atrophic changes in pancreas. It is established that older age of cystic fibrosis patients, progression of fibrotic and atrophic changes in pancreas as well as severe pulmonary insufficiency, all are predictors of deterioration in endocrine function of pancreas.
321 Clinical outcome in cystic fibrosis patients with or without meconium ileus Background: It has been documented that intestinal inflammation is one of the major features of cystic fibrosis (CF). However, the age of its onset is not well known. Therefore, we have aimed to assess whether intestinal inflammation is present in young CF infants at diagnosis. Material and Methods: The study comprised 10 infants detected in CF neonatal screening programme. The age of infants at the assessment was in range from 6 to 10 weeks. Intestinal inflammation was assessed by the measurement of fecal calprotectin concentrations (Immundiagnostik AG, Bensheim, Deutschland). Three children were pancreatic sufficient at the assessment (fecal elastase-1 concentrations: 200, 350 and 680 mcg/g of stool), the remaining seven were pancreatic insufficient (fecal elastase-1 concentrations from 6 to 33 mcg/g of stool).
Results:
The range of fecal calprotectin concentrations was from 7.5 to 400 mg/L (median 81.2; mean+SEM: 42.5+37.3). In 8 (80%) infants abnormal calprotectin results were obtained. The highest value, significantly different than in the other subjects, was observed in an infant who was operated due to meconium ileus. However, the second child who experienced meconium ileus and was treated in a conservative mode presented with normal calprotectin concentration (7.5 mg/L). No differences between pancreatic sufficient and insufficient patients were detected. However, all pancreatic sufficient subjects presented with abnormal calprotectin results.
Conclusions:
Intestinal inflammation is already present in young CF infants. 
